Developer docs
API playgroundTry for free, no card

Search company profiles

Siren Care

Full company profile

uuid00007rk

Namestring
Siren Care
Legal namestring
Siren Care, Inc.
Websiteurl
siren.care
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Siren Care, Inc. is a San Francisco-based medical device company founded in 2016 that has developed Siren Socks, an FDA-registered Class I medical device consisting of smart socks with embedded temperature sensors that continuously monitor foot temperature to detect early signs of inflammation in diabetic patients at risk of foot ulcers. The platform architecture pairs the proprietary smart textile sensors with the Siren Hub connectivity device, transmitting biometric data (temperature and moisture) to a remote patient monitoring backend where licensed nurses review temperature gradients and alert healthcare providers when plantar hotspots indicate developing injury, typically before visible symptoms appear.

The company operates a three-sided business model addressing patients with diabetes and neuropathy, healthcare providers (primarily podiatrists and primary care physicians enrolled through the Certified Siren Provider program), and health plans/payers (including Medicare, Medicare Advantage, private insurers, and the U.S. Department of Veterans Affairs). Revenue is generated through a combination of hardware sales of replacement socks (distributed automatically when worn out), recurring remote patient monitoring service fees reimbursed by public and private payers, and provider certification and ongoing education services. The broader Siren ecosystem now includes additional RPM devices (glucometer, blood pressure monitor, pulse oximeter, scale, and activity monitor) and the Principal Care Management program for chronic neuropathy management.

Siren has secured strategic backing from Mölnlycke Health Care via an $8 million investment in a $9.5 million round announced in January 2025, alongside earlier venture capital participation from DCM Ventures, Founders Fund, Khosla Ventures, and others. Real-world evidence cited by the company reports an 83% reduction in amputation risk and 68% reduction in foot ulcer risk among Siren Socks users, with $8,027 in net savings per patient per year relative to standard of care.

Short descriptiontext

Siren Care develops FDA-registered smart socks with embedded temperature sensors that continuously monitor diabetic patients' feet to detect early inflammation. The platform serves patients, healthcare providers, and health plans through Medicare-reimbursed remote patient monitoring and certified provider programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
smart textile monitoring, diabetic foot care, remote patient monitoring, medical device sensors, temperature monitoring socks
Industry3 codes
PRIMARYHLAHACAK
Continuous Temperature & Fever Monitoring (Wearable Thermometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYCRACAQAG
Thermometers & Temperature Monitoring (Smart Thermometers)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHSAHAHAI
Wearable Medical Alert Devices (Pendants, Watches, Bands)
Home & Personal Services/Home Security, Alarm & Smart Home Services/Personal Emergency Response Systems (PERS) & Medical Alert
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Smart Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Siren Socks Hardware Sales
TypeHardware Sales
Description

Sale of smart textile monitoring devices (Siren Socks) to patients, typically prescribed through healthcare providers or distributed via payer partnerships. Socks are replaced automatically when they wear down.

siren.care
2Remote Patient Monitoring (RPM) Services
TypeSubscription Recurring
Description

Continuous monitoring services where licensed nurses review temperature data and contact patients regularly. Providers receive reimbursement for RPM services through Medicare and private insurance.

siren.care
3Provider Certification and Network Services
TypeManaged Services
Description

Certified Siren Provider program trains healthcare providers in remote monitoring and virtual care services. Providers gain access to Siren's patient ecosystem and receive ongoing education (CRE - Continued RPM Education).

siren.care
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details2 tiers
1Medicare and Medicare Advantage Coverage
ModelSubscriptionBilling cadenceMonthly
Notes

Siren Socks are covered by Medicare and Medicare Advantage plans for eligible patients with diabetes and neuropathy.

siren.care
2Private Insurance Coverage
ModelSubscriptionBilling cadenceMonthly
Notes

Many private insurance plans cover Siren Socks for qualified patients.

siren.care
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Siren Socks
Description

Smart socks with embedded temperature sensors for diabetic foot monitoring

siren.care
+1 more record
Core offering1 text field

Siren Care manufactures and sells Siren Socks, an FDA-registered Class I medical device consisting of smart socks with temperature sensors hidden in the fabric that continuously measure foot temperature 24/7 in patients with diabetes and neuropathy. The socks connect via the Siren Hub to a monitoring platform where licensed nurses review temperature data, alert patients and providers to signs of inflammation, and enable remote patient monitoring services reimbursed by Medicare, Medicare Advantage, and private insurance. Siren also operates a Certified Siren Provider program training healthcare providers in remote monitoring and a Principal Care Management program for chronic conditions such as neuropathy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 87.5% reduction in diabetic foot ulcers with temperature monitoring
+5 more records
Product overview1 text field

Siren Care offers a platform-plus-devices ecosystem for diabetic foot ulcer prevention. The core product is Siren Socks, an FDA-registered Class I medical device with embedded temperature sensors that continuously monitor foot temperature. All Siren devices connect through the Siren Hub to a unified monitoring platform where licensed nurses review data and alert providers to potential injuries. The ecosystem includes additional remote monitoring devices (Siren Med, Siren Therapy, Siren Glucometer, Siren Blood Pressure Monitor, Siren Pulse Oximeter, Siren Scale, Siren Move) that work alongside the flagship Siren Socks. Services include Remote Patient Monitoring (RPM), the Certified Siren Provider training program, and Principal Care Management for chronic conditions like neuropathy.

Product and service5 records
1Siren Socks
CategorySmart medical device
Description

FDA-registered Class I medical device consisting of smart socks with temperature sensors hidden in the fabric that continuously measure foot temperature to detect early signs of inflammation and help reduce the risk of diabetic foot ulcers and amputations in patients with diabetes and neuropathy.

2Siren Hub
CategoryConnectivity hardware
Description

Central connectivity device that links all Siren products to the Siren platform for data transmission and remote patient monitoring, enabling continuous foot temperature data flow to licensed nurses and providers.

3Certified Siren Provider Program
CategoryProvider service program
Description

Training and certification program for healthcare providers in remote patient monitoring and virtual care services using Siren products, including Continued Remote Patient Monitoring Education (CRE), practice differentiation support, and access to Siren's patient ecosystem.

4Remote Patient Monitoring (RPM)
CategoryRemote monitoring service
Description

Virtual care service enabling healthcare providers to remotely monitor patients using Siren devices, including nurse monitoring, patient outreach, alerts for temperature changes, and provider coordination, reimbursed through Medicare and private insurance.

5Principal Care Management
CategoryCare management service
Description

Chronic condition management program initially launched for neuropathy, augmenting the diabetic foot program through Siren Certified Providers to deliver ongoing care management for patients with chronic diabetes-related conditions.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-19
Description

Partnership to provide Siren's temperature monitoring technology to active military and veterans living with diabetes and neuropathy. Siren is working to reduce the number of amputations among veteran populations through early detection of foot issues.

2Lovell Federal Health Care Center
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-01-19
Description

Partnership with Lovell Federal Health Care Center to extend critical preventative diabetic foot ulcer technology to active military and veteran populations.

siren.care
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Podimetrics makes a smart temperature monitoring mat that diabetic patients step on for 20 seconds daily to detect early signs of foot ulcers. It is the most direct competitor to Siren Socks in the temperature-based diabetic foot ulcer prevention category, targeting the same patient population, providers, and payers with a similar clinical value proposition.

TypeDirect peer
Description

Orpyx produces sensor-equipped insoles (Orpyx SI) that continuously monitor foot temperature, pressure, and other signals to prevent diabetic foot ulcers. It is a direct competitor to Siren in the diabetic foot ulcer prevention space, addressing the same patient population with continuous monitoring hardware reimbursed through similar RPM codes.

3Bonbouton
TypeEmerging player
Description

Bonbouton developed smart insoles with embedded sensors to monitor foot temperature and pressure for early detection of diabetic foot ulcers. It is an emerging direct competitor to Siren in continuous temperature-based foot monitoring, though with a smaller commercial footprint and different form factor (insole vs sock).

TypeBroad incumbent
Description

Vivify Health is an established remote patient monitoring platform used by health systems and payers for chronic disease management, including diabetes. It is a broader incumbent in the RPM space that Siren competes with for health plan contracts and provider attention, though Vivify's offering is software-first and disease-agnostic versus Siren's vertically integrated sock-and-platform approach.

5Health Recovery Solutions (HRS)
TypeBroad incumbent
Description

HRS provides a tablet-based remote patient monitoring platform used by hospitals and home health agencies to monitor patients with chronic conditions including diabetes. It competes with Siren for RPM reimbursement dollars and health system relationships, but operates as a hardware-agnostic software platform rather than a vertically integrated device company.

TypeBroad incumbent
Description

Dexcom is the leading continuous glucose monitor manufacturer and a major player in diabetes-related remote monitoring. While its product is CGM-focused rather than temperature-based, it serves the same diabetic patient population and has established relationships with endocrinologists, payers, and Medicare that Siren needs to access for population-scale deployment.

TypeBroad incumbent
Description

Abbott's FreeStyle Libre continuous glucose monitor franchise is a major diabetes monitoring incumbent with deep payer relationships and global distribution. Like Dexcom, Abbott is not a direct temperature-monitoring competitor but represents a scale player in the diabetes monitoring ecosystem where Siren operates and into which it could expand via the Siren Glucometer product.

TypeOthers
Description

Mölnlycke Health Care is a global wound care and surgical solutions leader that made an $8M strategic investment in Siren Care in January 2025. While not a competitor, Mölnlycke is the most strategically relevant partner for Siren — its wound care portfolio targets the same end prescribers (podiatrists, wound clinics) that Siren serves, making it both a channel partner and a potential acquirer.

TypeBroad incumbent
Description

Resideo's Life Care Solutions business provides remote patient monitoring services to health plans and home health agencies, including chronic condition monitoring for diabetes populations. It is a broader RPM incumbent that competes with Siren for payer contracts, though its offering is more focused on elderly fall risk and general vitals monitoring than diabetic foot ulcer prevention specifically.

TypeEmerging player
Description

Sensoria Health develops smart textile sensors embedded in socks and garments for health and activity monitoring, with applications in diabetic foot care, rehabilitation, and sports. It shares Siren's underlying smart-textile technology stack and form factor, but currently focuses more on activity tracking and rehabilitation rather than continuous temperature monitoring for diabetic foot ulcer prevention.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds15 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors18 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Siren Care

Smart Medical Devicessiren.care

Siren Care develops FDA-registered smart socks with embedded temperature sensors that continuously monitor diabetic patients' feet to detect early inflammation. The platform serves patients, healthcare providers, and health plans through Medicare-reimbursed remote patient monitoring and certified provider programs.

What Siren Care does

Siren Care, Inc. is a San Francisco-based medical device company founded in 2016 that has developed Siren Socks, an FDA-registered Class I medical device consisting of smart socks with embedded temperature sensors that continuously monitor foot temperature to detect early signs of inflammation in diabetic patients at risk of foot ulcers. The platform architecture pairs the proprietary smart textile sensors with the Siren Hub connectivity device, transmitting biometric data (temperature and moisture) to a remote patient monitoring backend where licensed nurses review temperature gradients and alert healthcare providers when plantar hotspots indicate developing injury, typically before visible symptoms appear.

The company operates a three-sided business model addressing patients with diabetes and neuropathy, healthcare providers (primarily podiatrists and primary care physicians enrolled through the Certified Siren Provider program), and health plans/payers (including Medicare, Medicare Advantage, private insurers, and the U.S. Department of Veterans Affairs). Revenue is generated through a combination of hardware sales of replacement socks (distributed automatically when worn out), recurring remote patient monitoring service fees reimbursed by public and private payers, and provider certification and ongoing education services. The broader Siren ecosystem now includes additional RPM devices (glucometer, blood pressure monitor, pulse oximeter, scale, and activity monitor) and the Principal Care Management program for chronic neuropathy management.

Siren has secured strategic backing from Mölnlycke Health Care via an $8 million investment in a $9.5 million round announced in January 2025, alongside earlier venture capital participation from DCM Ventures, Founders Fund, Khosla Ventures, and others. Real-world evidence cited by the company reports an 83% reduction in amputation risk and 68% reduction in foot ulcer risk among Siren Socks users, with $8,027 in net savings per patient per year relative to standard of care.

Siren Care firmographics

Firmographics
Name
Siren Care
Legal name
Siren Care, Inc.
Website
https://siren.care
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Siren Care develops FDA-registered smart socks with embedded temperature sensors that continuously monitor diabetic patients' feet to detect early inflammation. The platform serves patients, healthcare providers, and health plans through Medicare-reimbursed remote patient monitoring and certified provider programs.
Ownership category
akta.pro rank

Siren Care industry classification

Industry
Product category
Smart Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHACAK
Continuous Temperature & Fever Monitoring (Wearable Thermometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYCRACAQAG
Thermometers & Temperature Monitoring (Smart Thermometers)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHSAHAHAI
Wearable Medical Alert Devices (Pendants, Watches, Bands)
Home & Personal Services/Home Security, Alarm & Smart Home Services/Personal Emergency Response Systems (PERS) & Medical Alert

Keywords

  • Smart textile monitoring
  • Diabetic foot care
  • Remote patient monitoring
  • Medical device sensors
  • Temperature monitoring socks

Where Siren Care is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Siren Care business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Siren Socks Hardware Sales: Sale of smart textile monitoring devices (Siren Socks) to patients, typically prescribed through healthcare providers or distributed via payer partnerships. Socks are replaced automatically when they wear down.
  2. Remote Patient Monitoring (RPM) Services: Continuous monitoring services where licensed nurses review temperature data and contact patients regularly. Providers receive reimbursement for RPM services through Medicare and private insurance.
  3. Provider Certification and Network Services: Certified Siren Provider program trains healthcare providers in remote monitoring and virtual care services. Providers gain access to Siren's patient ecosystem and receive ongoing education (CRE - Continued RPM Education).

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyMedicare and Medicare Advantage Coverage
SubscriptionMonthlyPrivate Insurance Coverage

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Siren Care product offering

Product offering

Core offering

Siren Care manufactures and sells Siren Socks, an FDA-registered Class I medical device consisting of smart socks with temperature sensors hidden in the fabric that continuously measure foot temperature 24/7 in patients with diabetes and neuropathy. The socks connect via the Siren Hub to a monitoring platform where licensed nurses review temperature data, alert patients and providers to signs of inflammation, and enable remote patient monitoring services reimbursed by Medicare, Medicare Advantage, and private insurance. Siren also operates a Certified Siren Provider program training healthcare providers in remote monitoring and a Principal Care Management program for chronic conditions such as neuropathy.

Product overview

Siren Care offers a platform-plus-devices ecosystem for diabetic foot ulcer prevention. The core product is Siren Socks, an FDA-registered Class I medical device with embedded temperature sensors that continuously monitor foot temperature. All Siren devices connect through the Siren Hub to a unified monitoring platform where licensed nurses review data and alert providers to potential injuries. The ecosystem includes additional remote monitoring devices (Siren Med, Siren Therapy, Siren Glucometer, Siren Blood Pressure Monitor, Siren Pulse Oximeter, Siren Scale, Siren Move) that work alongside the flagship Siren Socks. Services include Remote Patient Monitoring (RPM), the Certified Siren Provider training program, and Principal Care Management for chronic conditions like neuropathy.

Differentiator

Problem solved

Functional benefit

Brands

  • Siren Socks: Smart socks with embedded temperature sensors for diabetic foot monitoring
  • Siren Sock

Products and services

  • Siren Socks FDA-registered Class I medical device consisting of smart socks with temperature sensors hidden in the fabric that continuously measure foot temperature to detect early signs of inflammation and help reduce the risk of diabetic foot ulcers and amputations in patients with diabetes and neuropathy.
  • Siren Hub Central connectivity device that links all Siren products to the Siren platform for data transmission and remote patient monitoring, enabling continuous foot temperature data flow to licensed nurses and providers.
  • Certified Siren Provider Program Training and certification program for healthcare providers in remote patient monitoring and virtual care services using Siren products, including Continued Remote Patient Monitoring Education (CRE), practice differentiation support, and access to Siren's patient ecosystem.
  • Remote Patient Monitoring (RPM) Virtual care service enabling healthcare providers to remotely monitor patients using Siren devices, including nurse monitoring, patient outreach, alerts for temperature changes, and provider coordination, reimbursed through Medicare and private insurance.
  • Principal Care Management Chronic condition management program initially launched for neuropathy, augmenting the diabetic foot program through Siren Certified Providers to deliver ongoing care management for patients with chronic diabetes-related conditions.

Quantifiable outcome

  • 87.5% reduction in diabetic foot ulcers with temperature monitoring
  • +5 more outcomes

Companies that use Siren Care

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles4 records

Siren Care technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Siren Care partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • U.S. Department of Veterans Affairs (VA)coreStrategic or Co-development Partner · 19 January 2022Partnership to provide Siren's temperature monitoring technology to active military and veterans living with diabetes and neuropathy. Siren is working to reduce the number of amputations among veteran populations through early detection of foot issues.
  • Lovell Federal Health Care CenterminorStrategic or Co-development Partner · 19 January 2022Partnership with Lovell Federal Health Care Center to extend critical preventative diabetic foot ulcer technology to active military and veteran populations.

Scale indicators10 records

Recent moves5 records

Expansion highlights6 records

Siren Care competitors and assessment

Company assessment

Direct peers

  • Podimetrics: Podimetrics makes a smart temperature monitoring mat that diabetic patients step on for 20 seconds daily to detect early signs of foot ulcers. It is the most direct competitor to Siren Socks in the temperature-based diabetic foot ulcer prevention category, targeting the same patient population, providers, and payers with a similar clinical value proposition.
  • Orpyx Medical Technologies: Orpyx produces sensor-equipped insoles (Orpyx SI) that continuously monitor foot temperature, pressure, and other signals to prevent diabetic foot ulcers. It is a direct competitor to Siren in the diabetic foot ulcer prevention space, addressing the same patient population with continuous monitoring hardware reimbursed through similar RPM codes.

Emerging players

  • Bonbouton: Bonbouton developed smart insoles with embedded sensors to monitor foot temperature and pressure for early detection of diabetic foot ulcers. It is an emerging direct competitor to Siren in continuous temperature-based foot monitoring, though with a smaller commercial footprint and different form factor (insole vs sock).
  • Sensoria Health: Sensoria Health develops smart textile sensors embedded in socks and garments for health and activity monitoring, with applications in diabetic foot care, rehabilitation, and sports. It shares Siren's underlying smart-textile technology stack and form factor, but currently focuses more on activity tracking and rehabilitation rather than continuous temperature monitoring for diabetic foot ulcer prevention.

Broad incumbents

  • Vivify Health: Vivify Health is an established remote patient monitoring platform used by health systems and payers for chronic disease management, including diabetes. It is a broader incumbent in the RPM space that Siren competes with for health plan contracts and provider attention, though Vivify's offering is software-first and disease-agnostic versus Siren's vertically integrated sock-and-platform approach.
  • Health Recovery Solutions (HRS): HRS provides a tablet-based remote patient monitoring platform used by hospitals and home health agencies to monitor patients with chronic conditions including diabetes. It competes with Siren for RPM reimbursement dollars and health system relationships, but operates as a hardware-agnostic software platform rather than a vertically integrated device company.
  • Dexcom: Dexcom is the leading continuous glucose monitor manufacturer and a major player in diabetes-related remote monitoring. While its product is CGM-focused rather than temperature-based, it serves the same diabetic patient population and has established relationships with endocrinologists, payers, and Medicare that Siren needs to access for population-scale deployment.
  • Abbott Diabetes Care: Abbott's FreeStyle Libre continuous glucose monitor franchise is a major diabetes monitoring incumbent with deep payer relationships and global distribution. Like Dexcom, Abbott is not a direct temperature-monitoring competitor but represents a scale player in the diabetes monitoring ecosystem where Siren operates and into which it could expand via the Siren Glucometer product.
  • Resideo Life Care Solutions: Resideo's Life Care Solutions business provides remote patient monitoring services to health plans and home health agencies, including chronic condition monitoring for diabetes populations. It is a broader RPM incumbent that competes with Siren for payer contracts, though its offering is more focused on elderly fall risk and general vitals monitoring than diabetic foot ulcer prevention specifically.

Others

  • Mölnlycke Health Care: Mölnlycke Health Care is a global wound care and surgical solutions leader that made an $8M strategic investment in Siren Care in January 2025. While not a competitor, Mölnlycke is the most strategically relevant partner for Siren — its wound care portfolio targets the same end prescribers (podiatrists, wound clinics) that Siren serves, making it both a channel partner and a potential acquirer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Siren Care social profiles

Digital presence

Siren Care compliance and trust

Trust signal

Compliance3 records

Siren Care financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Siren Care leadership team

Management profile

Number of profiles

Profiles7 records

Siren Care funding detail

Funding detail

Funding overview

Funding rounds15 records

Investors18 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Siren Care M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Siren Care

What does Siren Care do?

Siren Care manufactures and sells Siren Socks, an FDA-registered Class I medical device consisting of smart socks with temperature sensors hidden in the fabric that continuously measure foot temperature 24/7 in patients with diabetes and neuropathy. The socks connect via the Siren Hub to a monitoring platform where licensed nurses review temperature data, alert patients and providers to signs of inflammation, and enable remote patient monitoring services reimbursed by Medicare, Medicare Advantage, and private insurance. Siren also operates a Certified Siren Provider program training healthcare providers in remote monitoring and a Principal Care Management program for chronic conditions such as neuropathy.

Is Siren Care a public or private company?

Siren Care is a private company. It is classified as venture growth investor backed and is currently operating.

When was Siren Care founded?

Siren Care was founded in 2016. It employs 11 to 50 people.

Where is Siren Care based?

Siren Care is headquartered in San Francisco, United States, in the North America region.

How does Siren Care make money?

Three revenue lines are on record. Siren Socks Hardware Sales are the primary driver. The others are remote Patient Monitoring (RPM) Services and provider Certification and Network Services.

Who are Siren Care's main competitors?

Direct peers on record are Podimetrics and Orpyx Medical Technologies. Emerging players are Bonbouton and Sensoria Health. Broad incumbents are Vivify Health, Health Recovery Solutions (HRS), Dexcom, Abbott Diabetes Care and Resideo Life Care Solutions. Mölnlycke Health Care is listed as an others.

Does Siren Care have an API?

No public API is recorded for Siren Care.

What industry is Siren Care in?

Siren Care's product category is Smart Medical Devices. Its primary akta.pro industry code is HLAHACAK, Continuous Temperature & Fever Monitoring (Wearable Thermometry), with a secondary code of CRACAQAG, Thermometers & Temperature Monitoring (Smart Thermometers). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TechCrunchSiren secures strategic funding for its socks that detect diabetic foot ulcersSiren, a company making socks that detect diabetic foot ulcers, raised $9.5 million, with $8 million from lead investor Mölnlycke Health Care. The company has now raised $43 million total. The funding will support development and adoption of its product, with Mölnlycke helping expand availability in European markets.ButlertechnologiesTop Smart Clothing Items for 2023Butler Technologies, Inc. published an overview of the 2023 smart clothing market, highlighting products from Hexoskin, Under Armour, and Siren Care that integrate sensors for health and fitness tracking. The article details the technical shift from traditional wire sensors to conductive inks and fibers to improve comfort and integration in wearable garments. It concludes with a promotional call to action for clients interested in incorporating printed solutions into their own smart clothing applications.SirenSiren Continues to Gain Commercial Traction for Smart Fabric Remote Patient Monitoring Solution in COVID-19Siren, a developer of smart textile remote patient monitoring solutions, announced the final close of its Series B financing round, bringing the total raised to nearly $21 million. The company reported a 20x increase in monthly subscriptions and a 340% rise in signed patient contracts, driven by heightened demand for remote health services during the pandemic.AiThoritySiren Strengthens Presence in APAC With SECTION6 PartnershipSiren announced a partnership with Auckland-based SECTION6 to strengthen its APAC presence. The collaboration leverages SECTION6's Elastic partnership, embedding Elasticsearch into Siren's platform for real-time big data correlations. Siren expects the platform to provide significant value to SECTION6's client base.Venture Capital Access OnlineSiren Raises $11.8 Million to Power Commercial Expansion of its Smart Fabric Remote Patient Monitoring SolutionSiren, a medical device company specializing in smart fabric technology, has raised $11.8 million in Series B funding led by Anathem Ventures with participation from existing investors including DCM and Khosla Ventures. The capital will support the commercial expansion of its remote patient monitoring solutions, such as its FDA-registered temperature monitoring sock for diabetic foot ulcer detection. This development aligns with increased demand for virtual care and remote monitoring services driven by the COVID-19 pandemic.PR NewswireSiren Announces First Fully Integrated Remote Patient Monitoring Solution in PodiatrySiren announced Siren Staffing, a remote patient monitoring program for podiatry, with initial customers StrideCare and Village Podiatry Centers. The program uses Siren Socks to track foot temperature and licensed nurses to coordinate care, aiming to prevent diabetic foot ulcers. The company claims it offers the first fully integrated RPM solution in podiatry.HubsMetro Detroit strategic communication firm announces rebrand to better serve its expanding client rosterSiren, a metro Detroit strategic communication firm, rebranded by dropping 'PR' from its name to reflect its integrated communication and marketing services. The agency launched a new website and recently became the agency of record for Alliance Title of Michigan, Bateel USA, and others.MercomcapitalSiren Care Raises $9 Million for Smart Foot Ulcers Monitoring SocksSiren Care announced the closing of its Series B financing round, raising an additional $9 million to bring the total raised in this round to nearly $21 million. The funding includes participation from existing investors such as DCM and Khosla Ventures, alongside new investors Manta Ray, Mighty Capital, Portfolia, and David Helgason. This capital will support the expansion of its smart sock technology for diabetic foot ulcer monitoring.FinSMEsSiren Raises Additional $9M in Series B FinancingSiren, a San Francisco-based smart textile company, raised an additional $9M in Series B financing, bringing the round to nearly $21M. The company previously raised $11.8M earlier this year, and the new funding includes participation from existing and new investors. Siren's products include an FDA-registered temperature monitoring sock for diabetic foot ulcer detection.MobiHealthNewsSmart sock maker Siren adds $9M to this summer's Series BSiren, a smart sock maker, added $9 million to its $11.8 million Series B raise from new backers. The company reported monthly subscriptions increased nearly twenty-fold and patient contracts up 340% since COVID-19. It is rolling out cellular connectivity for remote monitoring.